Maria Jesus
Peñarrubia Ponce
Complejo Hospitalario de Toledo
Toledo, EspañaPublicacions en col·laboració amb investigadors/es de Complejo Hospitalario de Toledo (4)
2020
2015
2014
-
Do chronic myeloid leukemia patients with late “warning” responses benefit from “watch and wait” or switching therapy to a second generation tyrosine kinase inhibitor?
American Journal of Hematology, Vol. 89, Núm. 11, pp. E206-E211
2003
-
A randomized study of intermediate as compared with high doses of interferon-alpha for chronic myeloid leukemia: No differences in cytogenetic responses
Annals of Hematology, Vol. 82, Núm. 12, pp. 750-758